Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1-2 study of an antitumor agent (Japan, jRCT2080223847)
jRCT2080223847Phase 2Completed
- Start
- Mar 2018
01
Overview
Phase 2 trial in cancer. Started Mar 2018; status: completed.
02
Conditions
cancer
Beyond the preview
Go deeper on jRCT2080223847.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223847.